These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Targeted radiotherapy of multicell neuroblastoma spheroids with high specific activity [125I]meta-iodobenzylguanidine. Roa WH; Miller GG; McEwan AJ; McQuarrie SA; Tse J; Wu J; Wiebe LI Int J Radiat Oncol Biol Phys; 1998 May; 41(2):425-32. PubMed ID: 9607361 [TBL] [Abstract][Full Text] [Related]
23. Assessment of Organ Dosimetry for Planning Repeat Treatments of High-Dose 131I-MIBG Therapy: 123I-MIBG Versus Posttherapy 131I-MIBG Imaging. Pandit-Taskar N; Zanzonico P; Hilden P; Ostrovnaya I; Carrasquillo JA; Modak S Clin Nucl Med; 2017 Oct; 42(10):741-748. PubMed ID: 28759518 [TBL] [Abstract][Full Text] [Related]
24. Nuclear medicine therapy of neuroblastoma. Hoefnagel CA Q J Nucl Med; 1999 Dec; 43(4):336-43. PubMed ID: 10731784 [TBL] [Abstract][Full Text] [Related]
25. Tandem high-dose 131I-MIBG therapy supported by dosimetry in pediatric patients with relapsed-refractory high-risk neuroblastoma: the Bambino Gesu' Children's Hospital experience. Altini C; Villani MF; Di Giannatale A; Cassano B; Pizzoferro M; Serra A; Castellano A; Cannatà V; Garganese MC Nucl Med Commun; 2022 Feb; 43(2):129-144. PubMed ID: 34720106 [TBL] [Abstract][Full Text] [Related]
26. 131I-meta-iodobenzylguanidine in diagnosis and treatment of neuroblastoma. Voûte PA; Hoefnagel CA; de Kraker J Bull Cancer; 1988; 75(1):107-11. PubMed ID: 3359053 [TBL] [Abstract][Full Text] [Related]
27. HIGH-DOSE 131I-MIBG THERAPIES IN CHILDREN: FEASIBILITY, PATIENT DOSIMETRY AND RADIATION EXPOSURE TO WORKERS AND FAMILY CAREGIVERS. Cougnenc O; Defachelles AS; Carpentier P; Lervat C; Clisant S; Oudoux A; Kolesnikov-Gauthier H Radiat Prot Dosimetry; 2017 Apr; 173(4):395-404. PubMed ID: 26940442 [TBL] [Abstract][Full Text] [Related]
28. Therapeutic effect of m-[131I]- and m-[125I]iodobenzylguanidine on neuroblastoma multicellular tumor spheroids of different sizes. Weber W; Weber J; Senekowitsch-Schmidtke R Cancer Res; 1996 Dec; 56(23):5428-34. PubMed ID: 8968097 [TBL] [Abstract][Full Text] [Related]
29. Neuroblastoma therapy using radiolabelled [131I]meta-iodobenzylguanidine ([131I]MIBG) in combination with other agents. Mairs RJ Eur J Cancer; 1999 Aug; 35(8):1171-3. PubMed ID: 10615225 [No Abstract] [Full Text] [Related]
30. Nothing but NET: a review of norepinephrine transporter expression and efficacy of 131I-mIBG therapy. Streby KA; Shah N; Ranalli MA; Kunkler A; Cripe TP Pediatr Blood Cancer; 2015 Jan; 62(1):5-11. PubMed ID: 25175627 [TBL] [Abstract][Full Text] [Related]
31. [Therapeutic advances of nuclear medicine in oncology]. Valdés Olmos RA; Hoefnagel CA; Bais E; Boot H; Taal B; de Kraker J; Vote PA Rev Esp Med Nucl; 2001 Dec; 20(7):547-57. PubMed ID: 11709141 [TBL] [Abstract][Full Text] [Related]
32. Different outcomes for relapsed versus refractory neuroblastoma after therapy with (131)I-metaiodobenzylguanidine ((131)I-MIBG). Zhou MJ; Doral MY; DuBois SG; Villablanca JG; Yanik GA; Matthay KK Eur J Cancer; 2015 Nov; 51(16):2465-72. PubMed ID: 26254811 [TBL] [Abstract][Full Text] [Related]
33. [Follow-up evaluation of metastatic neuroblastoma using high dose [131I-meta]iodobenzylguanidine]. Klingebiel T; Reuland P; Feine U; Niethammer D Nuklearmedizin; 1992 Dec; 31(6):209-12. PubMed ID: 1491958 [TBL] [Abstract][Full Text] [Related]
34. Diagnosis and treatment of neuroblastoma using 131I-meta-iodobenzylguanidine. Edeling CJ; Büchler Frederiksen P; Kamper J; Jeppesen P Nuklearmedizin; 1986 Oct; 25(5):172-5. PubMed ID: 3797256 [TBL] [Abstract][Full Text] [Related]
35. A comparison of targeting of neuroblastoma with mIBG and anti L1-CAM antibody mAb chCE7: therapeutic efficacy in a neuroblastoma xenograft model and imaging of neuroblastoma patients. Hoefnagel CA; Rutgers M; Buitenhuis CK; Smets LA; de Kraker J; Meli M; Carrel F; Amstutz H; Schubiger PA; Novak-Hofer I Eur J Nucl Med; 2001 Mar; 28(3):359-68. PubMed ID: 11315605 [TBL] [Abstract][Full Text] [Related]
36. Combined use of chemotherapy and 131I-metaiodobenzylguanidine in the treatment of advanced-stage neuroblastoma. Sari O; Uğur O; Emir S; Akyüz C Turk J Pediatr; 2001; 43(1):29-33. PubMed ID: 11297155 [TBL] [Abstract][Full Text] [Related]
37. Radiation exposure to family caregivers and nurses of pediatric neuroblastoma patients receiving 131I-metaiodobenzylguanidine (131I-MIBG) therapy. Markelewicz RJ; Lorenzen WA; Shusterman S; Grant FD; Fahey FH; Treves ST Clin Nucl Med; 2013 Aug; 38(8):604-7. PubMed ID: 23797228 [TBL] [Abstract][Full Text] [Related]